Hepatic Encephalopathy ; diagnosis ; therapy ; Hepatitis, Viral, Human ; diagnosis ; therapy ; Humans

Embolization, Therapeutic ; Hepatic Encephalopathy/therapy* ; Humans ; Telangiectasia, Hereditary Hemorrhagic/therapy*

Hepatic Encephalopathy ; classification ; diagnosis ; therapy ; Humans ; Terminology as Topic

Adult ; Hepatic Encephalopathy ; therapy ; Hepatitis ; complications ; therapy ; Humans ; Liver Failure, Acute ; therapy ; Liver, Artificial ; Plasma Exchange

Hemoperfusion ; Hepatic Encephalopathy ; therapy ; Hepatitis, Viral, Human ; therapy ; Humans ; Liver, Artificial ; Plasma Exchange ; Sorption Detoxification

Amino Acids ; metabolism ; Hepatic Encephalopathy ; therapy ; Humans ; Intestines ; metabolism ; Liver, Artificial ; Neurotransmitter Agents ; metabolism

Adolescent ; Adult ; Female ; Hepatic Encephalopathy ; therapy ; Humans ; Liver, Artificial ; Male ; Middle Aged ; Renal Dialysis ; Sorption Detoxification

Current guideline developed by the Chinese Society of Hepatology on the management of hepatic encephalopathy in cirrhosis is grounded on the published evidences and panelists' consensus. This guideline presents recommendations for diagnosis and management of covert and overt hepatic encephalopathy, and underline the importance of screening minimal hepatic encephalopathy in patients with end-stage liver diseases. In addition, it also stresses that early identification and timely treatments are the means to know the prognosis. The principles of treatment are primary and secondary prevention, prompt removal of the cause, and recovery of acute neuropsychiatric abnormalities to baseline status.
Consensus ; Disease Management ; Gastroenterology ; Gastrointestinal Agents/therapeutic use* ; Hepatic Encephalopathy/drug therapy* ; Humans ; Liver Cirrhosis ; Practice Guidelines as Topic ; Prognosis

A 67-year-old woman presented with memory impairment and behavioral changes. Brain MRI indicated hepatic encephalopathy. Abdominal CT scans revealed an intrahepatic portosystemic venous shunt that consisted of two shunt tracts to the aneurysmal sac that communicated directly with the right hepatic vein. The large tract was successfully occluded by embolization using the newly available AMPLATZERTM Vascular Plug II and the small tract was occluded by using coils. The patient's symptoms disappeared after shunt closure and she remained free of recurrence at the 3-month follow-up evaluation.
Aged ; Embolization, Therapeutic/*instrumentation/methods ; Female ; Hepatic Encephalopathy/etiology/*therapy ; Hepatic Veins/abnormalities/radiography ; Humans ; Liver Circulation ; Portal Vein/abnormalities/radiography ; *Septal Occluder Device

Animals ; Brain Edema ; prevention & control ; therapy ; Cerebrovascular Circulation ; Dipeptides ; therapeutic use ; Hepatic Encephalopathy ; pathology ; prevention & control ; therapy ; Humans ; Naloxone ; therapeutic use